Cunningham D - Search Results

1

Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins.

Bott RK, Beckmann K, Zylstra J, Wilkinson MJ, Knight WRC, Baker CR, Kelly M, Maisey N, Waters J, Van Hemelrijck M, Smyth EC, Allum WH, Lagergren J, Gossage JA, Cunningham D, Davies AR. Bott RK, et al. Among authors: cunningham d. Acta Oncol. 2021 May;60(5):672-680. doi: 10.1080/0284186X.2021.1885057. Epub 2021 Feb 15. Acta Oncol. 2021. PMID: 33586602

2

New approaches to the treatment of gastro-intestinal cancer.

Waters JS, Ross PJ, Popescu RA, Cunningham D. Waters JS, et al. Among authors: cunningham d. Digestion. 1997;58(6):508-19. doi: 10.1159/000201494. Digestion. 1997. PMID: 9438595 Review.

3

Pre- and postoperative chemotherapy for resectable gastric adenocarcinoma.

Bancewicz J, Girling D, Allum W, Cunningham D, Stenning S. Bancewicz J, et al. Among authors: cunningham d. Ann R Coll Surg Engl. 1998 Jan;80(1):73. Ann R Coll Surg Engl. 1998. PMID: 9579137 Free PMC article. No abstract available.

4

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.

Waters JS, Norman A, Cunningham D, Scarffe JH, Webb A, Harper P, Joffe JK, Mackean M, Mansi J, Leahy M, Hill A, Oates J, Rao S, Nicolson M, Hickish T. Waters JS, et al. Among authors: cunningham d. Br J Cancer. 1999 Apr;80(1-2):269-72. doi: 10.1038/sj.bjc.6690350. Br J Cancer. 1999. PMID: 10390007 Free PMC article. Clinical Trial.

5

Colorectal cancer.

Waters JS, Cunningham D. Waters JS, et al. Among authors: cunningham d. Lancet. 1999 Mar 20;353(9157):1012-3. doi: 10.1016/S0140-6736(05)70721-2. Lancet. 1999. PMID: 10459935 No abstract available.

6

Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.

Popescu RA, Norman A, Ross PJ, Parikh B, Cunningham D. Popescu RA, et al. Among authors: cunningham d. J Clin Oncol. 1999 Aug;17(8):2412-8. doi: 10.1200/JCO.1999.17.8.2412. J Clin Oncol. 1999. PMID: 10561304

7

Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

Maisey NR, Hill ME, Webb A, Cunningham D, Flux GD, Padhani A, Ott RJ, Norman A, Bishop L. Maisey NR, et al. Among authors: cunningham d. Eur J Cancer. 2000 Jan;36(2):200-6. doi: 10.1016/s0959-8049(99)00249-x. Eur J Cancer. 2000. PMID: 10741278

8

Human Bcl-2 antisense therapy for lymphomas.

Cotter FE, Waters J, Cunningham D. Cotter FE, et al. Among authors: cunningham d. Biochim Biophys Acta. 1999 Dec 10;1489(1):97-106. doi: 10.1016/s0167-4781(99)00139-6. Biochim Biophys Acta. 1999. PMID: 10807000 Review. No abstract available.

9

FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study.

Maisey NR, Webb A, Flux GD, Padhani A, Cunningham DC, Ott RJ, Norman A. Maisey NR, et al. Among authors: cunningham dc. Br J Cancer. 2000 Aug;83(3):287-93. doi: 10.1054/bjoc.2000.1166. Br J Cancer. 2000. PMID: 10917540 Free PMC article. Clinical Trial.

10

Adjuvant chemotherapy.

Waters JS, Cunningham D. Waters JS, et al. Among authors: cunningham d. Lancet. 2000 Oct 7;356(9237):1276. doi: 10.1016/S0140-6736(05)73882-4. Lancet. 2000. PMID: 11072976 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,232 results

Search Page

Filters